Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment

被引：0

作者：

B. Sierakowski

K. Püchler

P. U. Witte

K. Renneisen

I. Roots

机构：

[1] Sankyo Europe GmbH,

[2] Immermannstrasse 45,undefined

[3] D-40210 Duesseldorf,undefined

[4] Germany Tel. +49 211 367 88-52; Fax +49 211 362 799,undefined

[5] Imform GmbH,undefined

[6] D-02826 Goerlitz,undefined

[7] Germany,undefined

[8] Institute of Clinical Pharmacology,undefined

[9] University Clinic Charité,undefined

[10] Humboldt University,undefined

[11] D-10098 Berlin,undefined

[12] Germany,undefined

来源：

European Journal of Clinical Pharmacology | 1997年 / 53卷

关键词：

Key words Temocapril; Renal failure;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Objective: The aim of this study was to determine the influence of renal impairment on the single-dose pharmacokinetics of temocapril and its pharmacologically active metabolite, temocapril diacid.

引用

页码：215 / 220

页数：5

共 50 条

[1] Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment
Sierakowski, B
Püchler, K
Witte, PU
Renneisen, K
Roots, I
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 53 (3-4) : 215 - 220
[2] Pharmacokinetics of temocapril and temocaprilat after 14 once daily oral doses of temocapril in hypertensive patients with varying degrees of renal impairment
Püchler, K
Eckl, KM
Fritsche, L
Renneisen, K
Neumayer, HH
Sierakowski, A
Lavrijssen, ATJ
Thomsen, T
Roots, I
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (06) : 531 - 536
[3] Single-dose pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment
de Jonga, Jan
Skee, Donna
Hellemans, Peter
Jiao, James
de Vries, Ronald
Swerts, Dominique
Lawitz, Eric
Marbury, Thomas
Smith, William
Sukbuntherng, Juthamas
Mannaert, Erik
LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 185 - 194
[4] Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different degrees of renal impairment
Türck, D
Weber, W
Sigmund, R
Budde, K
Neumayer, HH
Fritsche, L
Rominger, KL
Feifel, U
Slowinski, T
JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (02): : 163 - 172
[5] Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment
Thyrum, PT
Wong, YWJ
Yeh, C
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (04): : 521 - 533
[6] PHARMACOKINETICS OF TEMOCAPRIL AND ENALAPRIL IN PATIENTS WITH VARIOUS DEGREES OF RENAL-INSUFFICIENCY
OGUCHI, H
MIYASAKA, M
KOIWAI, T
TOKUNAGA, S
HORA, K
SATO, K
YOSHIE, T
SHIOYA, H
FURUTA, S
CLINICAL PHARMACOKINETICS, 1993, 24 (05) : 421 - 427
[7] Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment
Kato, Manabu
Tajima, Naoyuki
Shimizu, Takako
Sugihara, Masahiro
Furihata, Kenichi
Harada, Kazuhiro
Ishizuka, Hitoshi
JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (01): : 57 - 63
[8] Bucindolol (B) single dose pharmacokinetics (PK) in subjects with varying degrees of renal impairment.
Ogunremi, A
Swan, S
Gehr, T
Sica, D
Sellers, J
Roberge, P
Ward, D
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 158 - 158
[9] Single-dose pharmacokinetics and safety of daclatasvir in subjects with renal function impairment
Garimella, Tushar
Wang, Reena
Luo, Wen-Lin
Hwang, Carey
Sherman, Diane
Kandoussi, Hamza
Marbury, Thomas C.
Alcorn, Harry
Bertz, Richard
Bifano, Marc
ANTIVIRAL THERAPY, 2015, 20 (05) : 535 - 543
[10] SINGLE-DOSE PHARMACOKINETICS OF TEMOCAPRIL, AN ACE-INHIBITOR WITH PREFERENTIAL BILIARY-EXCRETION, IN DIALYSIS PATIENTS
TOKOO, M
OGUCHI, H
SATO, K
TERASHIMA, M
MIYASAKA, M
KASAHARA, H
SAITO, H
KAWAHARA, Y
SHIOYA, H
FURUTA, S
DRUG INVESTIGATION, 1994, 7 (05): : 254 - 261

← 1 2 3 4 5 →